Risperidone ODT 1mg Tablets

Manufacturer CADISTA Active Ingredient Risperidone Orally Disintegrating Tablets(ris PER i done) Pronunciation ris PER i done
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat schizophrenia.It is used to treat bipolar disorder.It is used to treat irritation that happens with autistic disorder.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Atypical Antipsychotic; Benzisoxazole Derivative; Dopamine and Serotonin Receptor Antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Dec 1993
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Risperidone is a medication used to treat certain mental health conditions like schizophrenia, bipolar disorder, and irritability related to autism. It works by helping to balance certain natural chemicals in the brain. The ODT (Orally Disintegrating Tablet) form dissolves quickly in your mouth, making it easier to take.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, as directed. Continue taking it as prescribed by your doctor or healthcare provider, even if you're feeling well.

When taking your medication, make sure to:

Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not necessary
Do not swallow the tablet whole, chew, break, or crush it

Storing and Disposing of Your Medication

To store your medication properly:

Keep it at room temperature, protected from light
Store it in a dry place, away from the bathroom
Keep all medications in a safe location, out of the reach of children and pets

When disposing of your medication:

Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on the best way to dispose of your medication
* Consider participating in a drug take-back program in your area, if available

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Take exactly as prescribed, do not stop abruptly without consulting your doctor.
  • Avoid alcohol and other CNS depressants as they can increase drowsiness.
  • Be aware of potential dizziness or lightheadedness, especially when standing up quickly. Rise slowly.
  • Monitor for weight gain and try to maintain a healthy diet and exercise routine.
  • Report any unusual muscle movements (tremors, stiffness, restlessness) or changes in menstrual cycle/breast discharge.
  • Stay hydrated, especially in hot weather, as this medication can affect body temperature regulation.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For schizophrenia, initial 2 mg/day, target 4-8 mg/day. For bipolar mania, initial 2-3 mg/day, target 1-6 mg/day. For irritability associated with autistic disorder, initial 0.5 mg/day, target 0.5-3 mg/day.
Dose Range: 0.5 - 8 mg

Condition-Specific Dosing:

schizophrenia: Initial 2 mg/day, target 4-8 mg/day, max 16 mg/day (rarely used). Doses >6 mg/day not shown to be more effective and associated with more EPS.
bipolar_mania: Initial 2-3 mg/day, target 1-6 mg/day. May be used as monotherapy or adjunct to lithium or valproate.
autistic_irritability: Initial 0.5 mg/day, titrate slowly based on weight and response. Target 0.5-3 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For irritability associated with autistic disorder (5-16 years): Initial 0.25 mg/day (for <20 kg) or 0.5 mg/day (for >=20 kg), titrate slowly. Max 3 mg/day. For schizophrenia (13-17 years): Initial 0.5 mg/day, target 3 mg/day. For bipolar mania (10-17 years): Initial 0.5 mg/day, target 1-2.5 mg/day.
Adolescent: For schizophrenia (13-17 years): Initial 0.5 mg/day, target 3 mg/day. For bipolar mania (10-17 years): Initial 0.5 mg/day, target 1-2.5 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial 0.5 mg twice daily, titrate slowly. Max 1.5 mg twice daily.
Severe: Initial 0.5 mg twice daily, titrate slowly. Max 1.5 mg twice daily.
Dialysis: Not well studied, but likely similar to severe impairment. Use with caution, monitor closely.

Hepatic Impairment:

Mild: No specific adjustment for mild impairment, but monitor closely.
Moderate: Initial 0.5 mg twice daily, titrate slowly. Max 1.5 mg twice daily.
Severe: Initial 0.5 mg twice daily, titrate slowly. Max 1.5 mg twice daily.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Risperidone is a selective monoaminergic antagonist with high affinity for serotonin 5-HT2A and dopamine D2 receptors. It also antagonizes alpha1-adrenergic and H1 histaminergic receptors. Antagonism at 5-HT2A and D2 receptors is thought to be responsible for its antipsychotic effects. The 5-HT2A antagonism may modulate D2 antagonism, reducing extrapyramidal symptoms (EPS) compared to typical antipsychotics.
📊

Pharmacokinetics

Absorption:

Bioavailability: 70% (oral solution/tablet), ODT formulation bioequivalent to conventional tablets.
Tmax: 1 hour (risperidone), 3 hours (9-hydroxyrisperidone).
FoodEffect: Food does not affect the rate or extent of absorption.

Distribution:

Vd: 1-2 L/kg (risperidone), 0.4 L/kg (9-hydroxyrisperidone).
ProteinBinding: 90% (risperidone), 77% (9-hydroxyrisperidone).
CnssPenetration: Yes

Elimination:

HalfLife: 3 hours (risperidone), 21 hours (9-hydroxyrisperidone).
Clearance: Not readily available as a single value, but primarily hepatic metabolism and renal excretion.
ExcretionRoute: 70% renal, 14% fecal.
Unchanged: Less than 10% (risperidone), 35-45% (total active moiety) excreted unchanged in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1-2 weeks for full antipsychotic effect, but some symptom improvement may be seen earlier.
PeakEffect: Peak plasma concentrations at 1 hour (risperidone) and 3 hours (9-hydroxyrisperidone). Clinical peak effect varies.
DurationOfAction: 24 hours (allows for once-daily dosing).

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone is not approved for the treatment of dementia-related psychosis.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Severe dizziness or fainting
Changes in behavior or mood
Shakiness, difficulty moving, or stiffness
Urination problems ( inability to pass urine or changes in urine output)
Trouble swallowing or speaking
Difficulty focusing
Seizures
Changes in vision
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, such as:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction or changes in menstrual cycle
Sexual problems, including:
+ Decreased libido
+ Ejaculation problems
Prolonged or painful erections (lasting more than 4 hours), which can lead to permanent sexual dysfunction if left untreated
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking or mental status
+ Rapid heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle disorder, which may cause:
+ Uncontrolled body movements
+ Tongue, face, mouth, or jaw problems (such as tongue sticking out, puffing cheeks, mouth puckering, or chewing)

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:

Weight gain
Restlessness
Dizziness, drowsiness, tiredness, or weakness
Anxiety
Gastrointestinal problems (constipation, diarrhea, stomach pain, upset stomach, or vomiting)
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
* Back, muscle, arm, or leg pain

If you experience any of these side effects or have concerns, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever, muscle stiffness, confusion, sweating, fast or irregular heartbeat (Neuroleptic Malignant Syndrome - NMS)
  • Uncontrolled muscle movements of the face, tongue, or other body parts (Tardive Dyskinesia)
  • Severe dizziness or fainting
  • Difficulty swallowing or breathing
  • Seizures
  • Signs of high blood sugar (increased thirst, increased urination, hunger, weakness)
  • Prolonged or painful erection (priapism)
  • Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Potential interactions with other medications or health conditions. This medication may affect or be affected by other drugs or health problems, so it is crucial to disclose all relevant information.

To ensure safe use, provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking
Natural products and vitamins you are using
* Any health problems you have

Carefully review your medications and health conditions to confirm that it is safe to take this medication in conjunction with them. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Information to Share with Your Healthcare Providers
Inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Precautions to Ensure Your Safety
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, stand up slowly after sitting or lying down, and be cautious when climbing stairs.

Potential Effects and Monitoring
It may take several weeks to experience the full effects of this medication. Be aware that medications like this one can increase the risk of high blood sugar, diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease. Monitor your blood sugar levels as directed by your doctor, and undergo regular blood tests as advised by your doctor.

Substance Interactions and Precautions
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription or over-the-counter medications that may cause drowsiness, consult with your doctor. In hot weather or during physical activity, drink plenty of fluids to prevent dehydration.

Potential Side Effects and Risks
This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and related injuries. If you have phenylketonuria (PKU), consult with your doctor, as some products contain phenylalanine.

Special Considerations for Older Adults
Older adults with dementia who take medications like this one have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Pregnancy, Fertility, and Breastfeeding
This medication may affect fertility, but this effect is reversible when the medication is discontinued. If you have questions or concerns, discuss them with your doctor. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to weigh the benefits and risks to you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Sedation
  • Tachycardia (fast heart rate)
  • Hypotension (low blood pressure)
  • Extrapyramidal symptoms (tremors, muscle stiffness, involuntary movements)
  • QTc prolongation
  • Seizures

What to Do:

Call 911 or Poison Control (1-800-222-1222) immediately. Seek emergency medical attention. Treatment is supportive, including maintaining airway, oxygenation, and ventilation. Gastric lavage and activated charcoal may be considered. Monitor cardiovascular function, including ECG, and treat hypotension and arrhythmias as needed. Do not induce vomiting.

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., opioids, benzodiazepines, alcohol): Increased sedation.
  • QTc-prolonging drugs (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of arrhythmias.
  • Dopamine agonists (e.g., levodopa, bromocriptine): Antagonism of effects.
  • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Significantly increase risperidone plasma levels.
  • Strong CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin): Significantly decrease risperidone plasma levels.
🟡

Moderate Interactions

  • Antihypertensives: Additive hypotensive effects.
  • Diuretics (especially in elderly with dementia): Increased risk of orthostatic hypotension and dehydration.
  • Drugs causing electrolyte imbalance (e.g., hypokalemia, hypomagnesemia): Increased risk of QTc prolongation.
  • Valproate: Increased risperidone levels (mechanism unclear, possibly displacement from protein binding).
đŸŸĸ

Minor Interactions

  • Cimetidine, ranitidine: Minor increase in risperidone levels.
  • Clozapine: May increase risperidone levels.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Weight, BMI

Rationale: Risk of weight gain and metabolic syndrome.

Timing: Before initiation

Fasting glucose/HbA1c

Rationale: Risk of hyperglycemia and new-onset diabetes.

Timing: Before initiation

Lipid panel (fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Blood pressure (orthostatic)

Rationale: Risk of orthostatic hypotension.

Timing: Before initiation

ECG

Rationale: Assess for baseline QTc prolongation, especially if risk factors present (cardiac disease, family history of sudden death, other QTc-prolonging drugs).

Timing: Before initiation (if indicated)

Prolactin levels

Rationale: Risk of hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction).

Timing: Before initiation (if indicated or symptomatic)

Abnormal Involuntary Movement Scale (AIMS)

Rationale: Assess for baseline dyskinesia.

Timing: Before initiation

📊

Routine Monitoring

Weight, BMI

Frequency: Monthly for first few months, then quarterly.

Target: Stable weight, healthy BMI.

Action Threshold: Significant weight gain (e.g., >5% baseline) warrants intervention.

Fasting glucose/HbA1c

Frequency: At 3 months, then annually.

Target: Normal glucose/HbA1c.

Action Threshold: Elevated levels require further evaluation and management.

Lipid panel (fasting)

Frequency: At 3 months, then annually.

Target: Normal lipid profile.

Action Threshold: Elevated levels require further evaluation and management.

Blood pressure (orthostatic)

Frequency: Weekly during titration, then periodically.

Target: Stable blood pressure.

Action Threshold: Significant orthostatic drop (e.g., >20 mmHg systolic, >10 mmHg diastolic) or symptomatic hypotension.

Extrapyramidal Symptoms (EPS) assessment (e.g., AIMS, SAS, BARS)

Frequency: Regularly, especially during dose titration and if symptoms emerge.

Target: Absence of EPS.

Action Threshold: Emergence of EPS (e.g., akathisia, dystonia, parkinsonism, tardive dyskinesia).

Prolactin levels

Frequency: Periodically if symptomatic (e.g., galactorrhea, amenorrhea, sexual dysfunction) or if long-term use.

Target: Normal prolactin levels.

Action Threshold: Symptomatic hyperprolactinemia.

Mental status and clinical response

Frequency: Ongoing.

Target: Improvement in target symptoms, stable mood/thought processes.

Action Threshold: Worsening symptoms, lack of efficacy, or emergence of new psychiatric symptoms.

đŸ‘ī¸

Symptom Monitoring

  • Sedation/drowsiness
  • Dizziness/lightheadedness (especially upon standing)
  • Muscle stiffness/tremor/restlessness (EPS)
  • Weight gain
  • Increased thirst/urination (signs of hyperglycemia)
  • Changes in menstrual cycle/galactorrhea (hyperprolactinemia)
  • Blurred vision
  • Constipation
  • Dry mouth
  • Sexual dysfunction
  • Agitation/anxiety (paradoxical effect)

Special Patient Groups

🤰

Pregnancy

Category C. Studies in animals have shown adverse effects on the fetus. There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Potential for developmental toxicity observed in animal studies. Data in humans are limited but do not suggest a major teratogenic risk.
Second Trimester: Risk of fetal exposure and potential for adverse effects on neurodevelopment.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder). Monitor neonates.
🤱

Lactation

Risperidone and its active metabolite (9-hydroxyrisperidone) are excreted into human milk. The relative infant dose (RID) is estimated to be low (around 1-2%). Monitor the infant for sedation, poor feeding, and developmental milestones. L3 (Moderately Safe).

Infant Risk: Low to moderate risk. Potential for sedation, irritability, poor feeding, and developmental delay. Weigh benefits of breastfeeding against potential risks. Consider using the lowest effective dose and monitoring the infant.
đŸ‘ļ

Pediatric Use

Approved for irritability associated with autistic disorder (5-16 years), schizophrenia (13-17 years), and bipolar mania (10-17 years). Dosing is weight-based for autism and age-based for schizophrenia/bipolar mania. Children and adolescents may be more susceptible to certain side effects like weight gain, hyperprolactinemia, and EPS. Close monitoring is essential.

👴

Geriatric Use

Elderly patients, especially those with dementia-related psychosis, are at increased risk of death when treated with antipsychotics (Black Box Warning). Increased risk of cerebrovascular adverse events (stroke, TIA). More susceptible to orthostatic hypotension and EPS. Start with lower doses and titrate slowly. Monitor for falls, sedation, and metabolic changes.

Clinical Information

💎

Clinical Pearls

  • Risperidone ODT can be taken with or without water. Place on the tongue, it will dissolve rapidly.
  • The ODT formulation is useful for patients who have difficulty swallowing pills or who may be non-adherent with conventional tablets.
  • High doses (>6 mg/day) are associated with a higher risk of EPS and hyperprolactinemia without significant additional efficacy for schizophrenia.
  • Monitor for metabolic side effects (weight gain, dyslipidemia, hyperglycemia) regularly, as these are common with atypical antipsychotics.
  • Hyperprolactinemia can lead to sexual dysfunction, amenorrhea, galactorrhea, and potentially long-term bone density issues. Consider monitoring prolactin if symptomatic.
  • Orthostatic hypotension is common, especially during initial titration. Advise patients to rise slowly and stay hydrated.
  • Be vigilant for signs of Neuroleptic Malignant Syndrome (NMS), a rare but potentially fatal adverse reaction.
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., olanzapine, quetiapine, aripiprazole, ziprasidone, lurasidone, cariprazine, brexpiprazole)
  • Typical antipsychotics (e.g., haloperidol, chlorpromazine) - generally less preferred due to higher EPS risk.
  • Mood stabilizers (e.g., lithium, valproate, lamotrigine) for bipolar disorder.
  • SSRIs/SNRIs for mood/anxiety symptoms (if comorbid or primary indication is not psychosis/mania).
  • Behavioral therapies and psychosocial interventions.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets (1mg ODT)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic), Tier 3 or higher (for brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.